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Primary open-angle glaucoma is the leading cause of irreversible blindness worldwide 
and intraocular pressure (IOP) reduction remains the only proven treatment strategy. 
Elevated IOP occurs due to impaired aqueous humour outflow. Both a passive model 
and a dynamic model have been used to explain trabecular outflow resistance. The 
passive model posits that the trabecular meshwork acts as a static filter that exerts 
stable and passive resistance to outflow. In contrast, the dynamic model involves a 
‘biomechanical pump.’ In recent years, the range of surgical management options for 
glaucoma has dramatically expanded, particularly the class of procedures known as 
micro-invasive glaucoma surgery (MIGS). These procedures typically have narrow 
mechanisms of action and enhance specific outflow routes. Optimal patient outcomes 
with MIGS requires a clear understanding of aqueous outflow and a surgical approach 
that is targeted to overcome the site of abnormal resistance in the individual. We 
review the anatomy and physiology of trabecular and suprachoroidal outflow that is 
of relevance to MIGS surgeons.  
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Introduction  
Primary open-angle glaucoma (POAG) is the leading cause of irreversible blindness 
worldwide74 and intraocular pressure (IOP) reduction remains the only proven 
treatment strategy.14 Since elevated IOP occurs due to impaired aqueous humour 
outflow, surgical treatments either enhance drainage through existing physiologic 
outflow pathways or divert aqueous into new, non-physiologic pathways (such as 
subconjunctival drainage). The research effort to characterize outflow resistance is 
intensive and ongoing, and a clear understanding is increasingly important in this era 
of highly targeted procedures known as micro-invasive glaucoma surgery (MIGS). 
Here we provide a comprehensive review of the anatomy and physiology of 






Aqueous outflow pathways 
Aqueous humour exits the eye via two routes: the trabecular pathway (Fig. 1a), and 
the non-trabecular pathway (Fig. 2). In the trabecular, or conventional outflow 
pathway, aqueous flows through the trabecular meshwork (TM) into Schlemm’s canal 
(SC) and then into a network of downstream vessels. The TM comprises three 
regions: uveal meshwork, corneoscleral meshwork and juxtacanalicular tissue (JCT) 
(Fig. 1a).84 The JCT is the outermost layer and abuts SC inner wall endothelium. 
Aqueous enters SC either by passing through pores in SC inner wall endothelium or 
by passing through transcanalicular microtubules (TCMs) (Fig. 1b).13 Cell processes 
of trabecular lamellae attach to the inner wall of the lumen and limit its outward 
movement by exerting restraining tension (Fig. 1c). From SC, aqueous flows into 
collector channel entrances (CCEs) and then into aqueous, episcleral and conjunctival 
veins.57 The trabecular outflow system can be subclassified into proximal and distal 
systems. The former refers to the TM (including the JCT), while the latter refers to the 






Fig. 1. (A) Trabecular outflow pathway. Cross-section showing layers of the TM that 
aqueous must traverse before entering SC. Aqueous exits SC through CCEs (outlet 
channels) located along the outer wall. Blue: uveal meshwork; red: corneoscleral 
meshwork; green: juxtacanalicular tissue.2 (B) TCMs arise from SC inner wall and 
extend across the lumen towards the outer wall.59 They are hollow and deliver 
aqueous into SC. Aqueous also enters SC by passing through pores in the SC inner 
wall endothelium. (C) Appearance of the trabecular outflow system at physiologic 
IOP. Arrows depict direction of aqueous flow. Cell processes attach to Schlemm’s 
canal endothelium (SCE) and exert restraining tension to limit its outward 
movement.51 (A) (Reprinted with permission. ©2010. Wolters Kluwer Health. All 
rights reserved), (B) (Reprinted with permission. ©1974. American Journal of 
Ophthalmology. All rights reserved), (C) (Reprinted with permission. ©2006. 
Springer Nature. All rights reserved). 
 
Aqueous also exits the eye via the unconventional pathway, which includes the 
uveoscleral, uveovortex and uveolymphatic routes (Fig. 2).29,50 The term “uveoscleral 
outflow” is often used in reference to all of these pathways but this is misleading. The 
preferred and more appropriate name is “non-trabecular outflow” and this term shall 
be used herein. It should be noted that a small amount of fluid also exits the eye via 
the corneal, iridial and retinal routes, but this flow is considered insignificant under 
physiological conditions.11,75 Non-trabecular outflow begins with seepage of aqueous 
through the anterior face of the ciliary muscle to reach the supraciliary and 
suprachoroidal spaces. From here, fluid can drain via three possible routes: (1) 
through connective tissue of the sclera (uveoscleral flow); (2) into choroidal vessels 
and then vortex veins (uveovortex flow);10,50 (3) into lymphatic vessels within the 
ciliary body (the uveolymphatic pathway) (Fig. 2). However, the existence of ciliary 
body lymphatic vessels is controversial.50  
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Fig. 2. Non-trabecular outflow pathway. Red arrow indicates direction of aqueous 
outflow. Aqueous can be seen to seep through the anterior face of the ciliary muscle 
to reach the supraciliary and suprachoroidal spaces. It then drains via three possible 
routes: (1) connective tissue of the sclera (uveoscleral flow); (2) choroid exiting via 
the vortex veins (uveovortex flow); (3) the lymphatic vessels within the ciliary body 
(the uveolymphatic pathway). 
 
The flow-limiting step of the non-trabecular pathway is the resistance imparted by the 
muscle bundles and connective tissue of the ciliary body. This resistance is increased 
by drugs that increase ciliary muscle tone such as pilocarpine,16 and is decreased by 
drugs that relax ciliary muscle tone, such as atropine and prostaglandin analogues. 
The latter have a slower, more significant hypotensive effect by reducing the amount 
of extracellular matrix between ciliary muscle bundles.50 Non-trabecular outflow 
decreases by approximately 3.5% per decade,87 which is attributable to an age-related 
increase in ciliary muscle connective tissue and a decrease in hydraulic conductivity 
of the sclera.3,29,85 
 
The percentage of aqueous outflow draining via the non-trabecular pathway in 
humans is uncertain due to inherent difficulties in measuring this flow. Estimates vary 
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widely from less than 10% to more than 70% of total aqueous outflow, with 
measurement technique errors thought to account for most of the discrepancy.50 
It is commonly quoted that non-trabecular outflow comprises approximately 50% of 
outflow in young healthy individuals but this flow declines with age and in 
glaucoma.29,50,87,88 
 
Physiology of non-trabecular outflow 
Evidence suggests that non-trabecular flow is driven by both hydrostatic and osmotic 
forces operating synergistically. Aqueous moves from the anterior chamber to the 
supraciliary space and then to the suprachoroidal space by travelling down a small 
hydrostatic pressure gradient. Emi and colleagues measured this gradient in a pivotal 
study of anaesthetized monkeys.24 At an IOP of 15mmHg, pressure was 1mmHg 
lower in the supraciliary space and 4mmHg lower in the suprachoroidal space. Brisk 
drainage of fluid from the suprachoroidal space is thought to account for the lower 
pressures in this compartment. It has also been suggested that a “compact zone” of 
more densely packed collagenous tissue at the level of the ora serrata imparts 
resistance to flow between the supraciliary and suprachoroidal spaces, however the 
existence of this tissue is controversial.64 
 
Aqueous reaching the suprachoroidal space predominately enters the choroidal 
vasculature by osmosis to drain via the uveovortex pathway. The uveoscleral pathway 
is driven by hydrostatic pressure and is likely much less important at physiologic 
IOPs.24 In the monkey study by Emi and colleagues, rapidly lowering the IOP from 
60mmHg to 5mmHg caused the pressure in the suprachoroidal space to become 
negative relative to atmospheric pressure. The authors reasoned that hydrostatically-
driven uveoscleral flow could never produce negative pressures.24 The predominate 
mechanism for drainage must therefore be uveovortex flow, driven by a large 
colloidal osmotic gradient. Further evidence for this comes from cyclodialysis studies, 
which have recorded profound hypotony despite relatively normal aqueous production 
rates on fluorphotometric testing.83 When IOP is below episcleral venous pressure 
(EVP) non-trabecular flow must be the sole route of aqueous drainage, however, at 
low IOP there is inadequate hydrostatic pressure to drive the uveoscleral pathway. 
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Therefore, uveovortex outflow must underpin hypotony after cyclodialysis and must 
also be capable of draining large volumes.  
 
Hydrostatic pressure in the suprachoroidal space is also important to uveovortex 
outflow. Positive pressure inhibits serum proteins diffusing out of the choroidal 
vasculature, which is freely permeable. Consequently, a large colloidal osmotic 
gradient can be maintained.24,29 During hypotony, proteins exit the choroidal vessels 
but are too large to pass through the sclera. They therefore accumulate in the 
suprachoroidal space and contribute to the development of choroidal effusions.29 It is 
important to point out a misunderstanding that commonly appears in physiology texts. 
That is, at IOPs below 7mmHg, fluid in the suprachoroidal space is unable to drain 
because hydrostatic pressure is lower than orbital pressure, resulting in choroidal 
effusions. This mechanism is incorrect because it falsely assumes that uveoscleral 
flow, driven by hydrostatic pressure, is the main route of non-trabecular outflow.62  
 
A defining feature of non-trabecular outflow is that it is relatively unaffected by 
IOP.50 In the monkey studies by Emi and colleagues,24 increasing the IOP from 
15mmHg to 60mmHg only increased the pressure difference between the AC and the 
suprachoroidal space from 4mmHg to 10mmHg. Thus, huge IOP spikes cause only a 
small increase in the pressure gradient driving non-trabecular flow, which remains 
fairly constant between an IOP of 4mmHg to 35mmHg.9 In addition, increased IOP 
does not affect the colloid osmotic gradient pulling aqueous into the choroidal 
circulation, which is the main determinant of uveovortex flow.50 Prior to the work of 
Emi and colleagues,24 Bill11 had proposed the “elastic sponge model” to explain how 
non-trabecular flow is IOP insensitive. This postulated that elevated IOP compressed 
the interstitial spaces between ciliary muscle bundles, resulting in increased 
resistance. However, it is inconsistent with several observations of outflow 
physiology and has now been superceded.50 Non-trabecular flow can be rendered 
more IOP dependent by bypassing ciliary body resistance with cyclodialysis or a 
supraciliary stent. This eradicates most of the resistance to non-trabecular outflow and 
results in a four-fold increase in aqueous drainage, and may also lower IOP by focally 
interrupting ciliary body perfusion.8,83 It has been hypothesized that in the initial 
stages of glaucoma there is increasing levels of trabecular resistance, with redirection 
of flow into the non-trabecular pathway, which is IOP insensitive.86  
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Trabecular outflow  
Outflow resistance of the trabecular pathway: a brief history  
In 1958 and 1963, Grant39,40 published two studies that are considered seminal, 
because they demonstrated that IOP control and loss of IOP regulation in glaucoma 
can be localized to the outflow system. In these experiments normal enucleated eyes 
were cannulated to a constant-pressure outflow apparatus and the TM was 
progressively dissected ab interno to correlate the depth of TM dissection with the 
increase in outflow facility. Grant39,40 demonstrated that a 360 degree ab interno 
trabeculotomy eliminated 75% of outflow resistance in normal eyes. This finding was 
later misinterpreted to mean that 75% of normal outflow resistance, and all of the 
increased resistance in open-angle glaucoma, is localised to the TM. 
 
Grant39,40 reported that outflow resistance was largely unaffected by incisions into the 
uveal and proximal corneoscleral meshwork. However, deeper incisions traversing 
full-thickness TM and inner wall of SC caused a profound reduction in outflow 
resistance. This finding lead to the erroneous conclusion that trabecular outflow 
resistance is localized to the juxtacanalicular portion of the TM and the inner wall of 
SC. This belief quickly gained traction in the literature and continues to be propagated 
by review articles in recent times.12,28,34,49,72 
 
Over the following years, Grant and colleagues22,23 published studies that superseded 
their earlier experiments and indicated alternate mechanisms for outflow resistance. 
These studies proposed that outflow resistance was not simply a product of TM 
permeability but was caused by collapse of SC and higher downstream resistance than 
previously thought. Their findings are particularly relevant today as they help to 
explain why trabecular microbypass stents do not lower IOP to EVP.56 They also 
measured the change in outflow resistance of internalizing SC with ab interno 
trabeculotomy, and compared this to externalizing SC by removing the outer wall of 
SC and overlying sclera.23 They demonstrated that 360 degree ab interno 
trabeculotomy eliminated only 27% of the total outflow resistance at an IOP of 
10mmHg but 62% at an IOP of 20mmHg.23 Paradoxically, removing the external wall 
of SC and overlying sclera (leaving the TM and inner wall of SC intact) also 
 10 
eliminated 75% of the outflow resistance, leaving only 25% of the resistance to be 
accounted for by the TM.23 In order to reconcile these seemingly contradictory 
findings Ellingsen and Grant23 concluded that “resistance to aqueous outflow may 
normally depend in part upon an intact and unyielding outer wall of SC against which 
an intact inner wall is pressed by the IOP.” Removing either the SC inner wall or the 
SC outer wall eliminates approximately 75% of outflow resistance by preventing 
apposition of these walls. 
 
Despite Grant’s valuable contribution to aqueous outflow physiology there are some 
important limitations to consider when interpreting his findings. An often-overlooked 
detail of Grant’s26 experiments is the elevated perfusion pressure used to measure 
outflow facility. The ex vivo eyes in Grant’s studies were perfused at an IOP of 
25mmHg. This is equivalent to an intracameral pressure of approximately 33mmHg 
in vivo, given the absence of EVP in cadaver eyes (assuming EVP is 8mmHg).57 In 
light of the abnormally high perfusion pressures used, Rosenquist et al.77 repeated 
Ellingsen and Grant’s23 earlier trabeculotomy experiments. In their study, they 
compared a lower IOP (7mmHg) and higher IOP (25mmHg), and reported reductions 
in outflow resistance up to 49% and 75%, respectively with 12 clock hour 
trabeculotomy (Fig. 3).77 They concluded that at low IOPs, a relatively high portion of 
aqueous outflow resistance is situated downstream from SC but at higher IOPs this 
distal resistance is less important.77  
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Fig. 3. Percentage of baseline resistance eliminated by sequential 1, 4 and 12 clock 
hour internal trabeculotomy in enucleated human eyes at 7mmHg vs. 25mmHg 
perfusion pressure.77 (Reprinted with permission. ©1989. Taylor & Francis. All rights 
reserved.) 
 
Further research in Grant’s22 lab demonstrated that outflow facility decreases as IOP 
increases, being more pronounced in glaucomatous eyes than normal eyes. Outflow 
facility declines gradually during prolonged periods of raised IOP, indicating that 
progressive changes to the outflow pathways occur.22 To explain this finding, the 
authors consulted advisors in fluid mechanics. They postulated that the outflow 
system must not be geometrically fixed, but rather is physically altered by increasing 
flow and pressure.22 They concluded that contact between the TM and SC outer wall 
was responsible for the increased resistance at higher IOPs.22 The rise in outflow 
resistance becomes most evident at pressure levels where the canal begins to 
collapse.89,90 IOP-dependent apposition of the TM against the SC outer wall has since 
been confirmed by numerous studies, including recent investigations using phase-
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sensitive optical coherence tomography (PhS-OCT).41-43,48,58,67,68 In the human eye, 
SC closure occurs even at relatively low pressures.58  
 
Tensioning the TM to inhibit its excursion to the SC outer wall approximately halves 
trabecular outflow resistance.40 This can be demonstrated experimentally by 
manipulating ciliary body tension or by depressing the lens posteriorly.22,89,90 Lens 
depression eliminates nearly all of the IOP-related increase in outflow resistance up 
until an IOP of 40mmHg.89,90 Tension on the ciliary body places tension on the scleral 
spur, which in turn pulls the TM away from the SC outer wall.57 The increase in 
outflow facility is reversed by returning the lens to the neutral position or by 
disinserting the ciliary body from the scleral spur.40 Conversely, outflow resistance is 
increased by rotating the ciliary body anteriorly (independent of the presence or 
absence of iris tissue).40 At the time of performing these experiments it was 
hypothesized that tensioning the TM was increasing the permeability of the 
meshwork. While this may be true, the significance of SC collapse was only 
appreciated later.   
 
Certain surgical procedures provide insight into the relative contributions that TM 
permeability and dynamic TM movement each have on outflow resistance. Nd-YAG 
laser trabeculopuncture aims to bypass proximal resistance by cutting holes through 
the TM into SC.25,70 In a study conducted in monkeys, trabeculopuncture lowered IOP 
by up to 12mmHg.70 However, IOP measurements returned to baseline by day eight 
due to healing of the puncture sites.70 Excimer laser trabeculostomy (ELT), a 
procedure based upon the same outflow principles as Nd-YAG trabeculopuncture, 
minimizes the healing response by using photoablation without inducing thermal 
damage.7 The procedure involves the creation of 10 laser ablations (trabeculostomies) 
distributed across 1 quadrant of the angle.7 Similar to Nd-YAG trabeculopuncture, it 
theoretically allows aqueous to bypass the permeability resistance of the TM, yet the 
procedure would not be expected to prevent collapse of SC. Pache et al.73 reported on 
135 eyes with open-angle glaucoma or ocular hypertension treated with ELT as a 
standalone procedure. In the subgroup of individuals with baseline IOP >22mmHg, a 
mean IOP reduction of 31% was achieved (baseline mean IOP 27.9  3.9mmHg, 1 
year mean IOP 19.3  5.5mmHg). Individuals with baseline IOP ≤21mmHg achieved 
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a mean IOP reduction of 13% (baseline mean IOP 20.2  1.1mmHg, 1 year mean IOP 
17.6  3.3mmHg).73 As illustrated in Fig. 3, these pressure reductions in the latter 
group are approximately half of what the studies of Rosenquist,77 Grant and 
Ellingsen22,23 would predict for a trabeculotomy involving 1 quadrant. The 
trabeculotomy, which addresses both TM permeability and SC collapse, appears to 
achieve greater IOP reductions than ELT, which only bypasses TM permeability 
resistance. This suggests that both TM permeability and SC collapse are important 
mechanisms in trabecular outflow resistance.   
 
A unifying model to explain all of the observations on trabecular resistance must 
incorporate both SC closure (dynamic) and TM permeability resistance (passive). 
Three key points should be emphasized in regards to the trabecular outflow pathway. 
Firstly, SC closure is important and accounts for the dramatic increase in outflow 
resistance as IOP rises. It also explains why this increase in resistance is eliminated by 
tensioning the scleral spur posteriorly or by removing either the inner wall or outer 
wall of SC.22,23,77 Secondly, the TM imparts a passive resistance to permeability, as 
demonstrated by the immediate IOP-lowering effect of Nd-YAG trabeculopuncture or 
ELT.70 Further evidence is found in the dissection studies of Ellingsen and Grant.23 In 
1972 they reported that if they accidentally pierced the TM while removing the SC 
outer wall the outflow resistance was dramatically lower than if the TM remained 
intact.23 In addition, it is self-evident that TM permeability and TM motion must be 
coexistent phenomena, as only tissues resisting a force undergo deformation. Thirdly, 
resistance downstream from SC accounts for a significant proportion of outflow 
resistance at low-normal IOPs.77  
 
Passive model of trabecular resistance  
The traditional model posits that the TM acts as a filter that exerts stable and passive 
resistance to outflow. The resistance is entirely dependent on its permeability, which 
is regulated by changes in the extracellular matrix of the JCT.32,71 The model relies on 
the assumption that the JCT has a geometrically stable structure that is not 
significantly altered by short-term IOP fluctuations.57 Several pieces of evidence have 
already been highlighted that argue against this model as being solely responsible for 
trabecular outflow resistance.52,55  
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Modern histologic studies indicate that the JCT has insufficient extracellular matrix to 
solely account for the resistance of the trabecular pathway.31,35,57 27,81 The JCT 
became the favoured candidate for trabecular resistance based upon studies of 
enucleated eyes that were typically fixed under conditions of hypotony.53 Such 
conditions made the JCT appear more compact than it is in vivo.53 In contrast, the 
spaces in the uveal and corneoscleral meshwork are too large to provide meaningful 
levels of resistance.13,49,84 A more general argument against the passive model is that 
it implies that most structural elements of the TM serve no purpose, which seems 
counter-evolutionary.52 For example, in the passive model it would appear that the 
trabecular beams (lamellae) and surrounding cells, which comprise the majority of the 
TM, serve no function.52   
 
Dynamic model of trabecular resistance  
The dynamic model proposes that trabecular outflow involves a ‘biomechanical 
pump’ that is powered by the ocular pulse pressure, blinking, and saccadic eye 
movements.22,23,58,89,90 The flexible TM distends and recoils in sync with the cardiac 
cycle, actively moving aqueous into SC. Unlike the passive model, the dynamic 
model links trabecular structure and function. All components of the TM have 
functional significance including the trabecular lamellae, JCT, SC inner wall 
endothelium and TCMs.52 Our understanding of this model is largely derived from the 
work of Murray Johnstone.52,53,61  
 
Ex vivo histologic58,61 and PhS-OCT67,68 research indicates that the TM moves 
outward during pulse-synchronous increases in IOP. During systole, the outward 
movement of the TM increases pressure in SC, compressing its lumen and forcing 
aqueous into collector channels and aqueous veins. During diastole, the IOP drops 
and the TM recoils towards the AC, which reduces the pressure in SC and allows 
entrance of aqueous from the AC.54 The ocular pulse amplitude in normal eyes is 
approximately 3mmHg63 and blinking and eye movements generate forces of 
10mmHg,51 providing ample energy to power this system.  
 
When IOP is raised, the TM is stretched towards the SC outer wall.60 This stretching 
moves the trabecular tissues up their length-tension curve, resulting in an increased 
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force of recoil with the minor fluctuations in IOP occurring during the cardiac 
cycle.51,61 In normal eyes this causes the stroke volume of the trabecular pump to 
increase, which helps to return IOP back towards its homeostatic set point.51,61 This 
can be seen as increased pulsatile flow within aqueous veins.60 As IOP rises, stoke 
volume will continue to increase up until the point that SC closure occurs.51,61 The 
power of the trabecular pump is dependent upon the recoil force of the TM, which is 
dependent upon its elasticity and the tension exerted by the scleral spur.60 In this way, 
short term IOP regulation is mediated by changes in stroke volume, and long term 
IOP regulation is mediated by changes in the intrinsic distension and recoil 
characteristics of the extracellular matrix of the trabecular lamellae.51 The trabecular 
lamellae and SC endothelium must maintain distension-recoil responses within a 
narrow range to maintain normal IOP homeostasis. In this way, the entire TM and SC 
complex becomes a tensionally-integrated system able to sense strain and alter its 
biomechanical characteristics accordingly.51,60 
 
In glaucoma, the TM becomes stiffer and loses its elasticity and recoil.92 The result is 
a progressive decline in trabecular movement, which in turn decreases the efficiency 
of the trabecular pump. As IOP climbs, the SC inner wall is pushed into appositional 
closure against the SC outer wall and herniations of TM into CCE are seen (Fig. 4).36 
In normal eyes, transient SC closure is a normal phenomenon that can occur at 
relatively low IOPs and is entirely reversible. However, in glaucomatous eyes, SC 
closures and TM herniations are less reversible,36 possibly as a result of a less pliable 
TM and more prolonged and frequent episodes of SC closure. Aqueous cannot enter a 
collapsed SC, and neither can it travel circumferentially within a collapsed SC to 
reach collector channels. Consequently, the area of angle available for aqueous 
drainage decreases, resulting in higher IOPs. This creates a vicious cycle culminating 





Fig. 4. Light microscopy images of CCE of normal eyes. (A) At a perfusion pressure 
of 45mmHg, SC is collapsed and TM is herniating into CCE. (B) At a perfusion 
pressure of 7mmHg, SC is open and no herniations are visible.38 SC, Schelmm’s 
canal; CC, collector channel. (Reprinted with permission. ©2014. Springer. All rights 
reserved). 
 
Clinical manifestations of a failing trabecular biomechanical pump 
Several clinical manifestations of pump failure can be used to assess the health of the 
trabecular pathway and estimate the success of trabecular MIGS procedures. In a 
significant proportion of normal eyes there is pulse-synchronous flow within aqueous 
veins, which becomes more vigorous as IOP is elevated.5,65 Johnstone51,61 proposes 
that this is evidence of a healthy trabecular pump that can change its stroke volume 
with IOP. In contrast, pulsatile flow is sluggish or absent in glaucomatous eyes. When 
it is present it tends to disappear with only small increases in IOP (as measured with 
ophthalmodynamometry), and the aqueous veins then undergo retrograde filling with 
blood.5,65 51 The explanation for this is that SC closure occurs when IOP is raised even 
a small amount, and this causes the pressure in aqueous veins to fall below EVP, 
which causes retrograde blood filling.51 These observations suggest impaired 
trabecular pump function in glaucoma.  
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Schlemm’s canal  
Schlemm’s canal was first described by Friedrich S. Schlemm80 in 1830 after 
observing this structure in the eye of a man who had been hung. Since it was filled 
with blood at the time, he considered it to be a venous sinus.80 Its role in aqueous 
humour drainage and outflow resistance was subsequently investigated by numerous 
authors.   
 
In 1934, ocular pathologist Georgiana Dvorak-Theobald20 undertook a detailed 
anatomical study of SC, believing that “anatomic variations have an important 
bearing upon clinical pathology.” She dissected a human eye into 810 serial sections, 
each 15μm thick, cut horizontally, the first and last section being through the outer 
margins of SC. For each section she outlined the lumen of the vessels on a different 
sheet of paper to eventually reproduce wax models of SC with its anatomic relations 
to veins, arteries and nerves.20 Using the models she was able to demonstrate that SC 
does not consist of a sharp inner margin which one is accustomed to seeing in 
textbook illustrations, but rather its border with the trabeculae is highly irregular.20  
 
In 1951, Norman Ashton6 produced even more detailed models of SC and aqueous 
veins using neoprene casting. This technique, which was first used by Lieb69 in 1940 
for renal vascular studies, is well suited to demonstrating the complex relationship of 
SC to the downstream collectors (Fig. 5). From his model, Ashton6 concluded that 
aqueous veins either arise directly from SC or communicate with it indirectly via 






Fig. 5. (A) Neoprene cast of SC demonstrating two aqueous veins. Blue asterix 
denotes SC. Red arrows denote aqueous vein arising directly from SC. Yellow arrows 
denote aqueous vein indirectly arising from SC via anastamotic branches between the 
superficial and deep scleral plexuses. (B) Drawing from neoprene cast shown in Fig. 
3a. Deep scleral plexus is shown in dark green. Superficial scleral plexus is depicted 
in light green. The aqueous vein on the left arises directly from SC by a hook-shaped 
origin. The aqueous vein on the right does not directly connect with the canal.6 
(Reprinted with permission. © 1951. BMJ. All rights reserved). 
 
These findings have since been adapted and simplified into anatomy textbook 
descriptions, such as ‘Clinical Anatomy of the Eye’ by Snell and Lemp.82 Here SC is 
described as “a sinus, which is oval or triangular in cross section.” The illustrations 
depict a well-demarcated circular structure. The problem with this common 
description is that it neglects the functional aspect of the tissue including its ability to 
dynamically change shape in response to IOP fluctuations. Therefore, this 
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conceptualization of the anatomy can inadvertently lead to a misunderstanding of the 
physiology.  
 
Collector channel entrances  
CCEs or ostia refer to the entrance point of collector channels that exit from the 
external wall of SC. They typically turn abruptly to join a deep scleral plexus of 
collector vessels that are typically orientated parallel to SC.57 Histological studies of 
human eyes indicate that CCEs vary greatly in size (from 5μm to 70μm) and are more 
numerous in the infero-nasal quadrant.21,46,76 Their location is of particular relevance 
to trabecular microbypass stents because there is preferential drainage through TM 
adjacent to CCEs and minimal circumferential flow within SC.39,45 
 
There is emerging evidence that CCEs open and close and thus play a role in 
regulating outflow resistance.47,48 Scanning electron microscopy reveals hinged 
septate at the CCEs – a configuration that permits rapid movement in response to 
pressure changes (Fig. 6).57 This was first reported by Rohen and Rentsch76 in 1968, 
who identified collagen flaps at CCEs as an important source of resistance, claiming 
that the flaps are held open by attachments to the TM. The more recent mechanism 
proposed is that highly elastic TCMs connect the TM to the hinged collaged flaps, 
thereby allowing CCEs to open and close in synchrony with pressure-dependent 
movement of the TM.57 This is supported by recent studies using high-resolution 
OCT.48 Cells containing smooth muscle myosin have been identified near CCEs but a 




Fig. 6. Collector channel entrance (CCE) and hinged collagen flaps (HCF) in deep 
scleral plexus. SC can be seen opening into a CCE. Two hinged collagen flaps can be 
seen surrounding the convoluted pathway into the intrasclaeral collector channels 
(ISCC). Black T denotes hinge locations. Green outline denotes JCT space. White 
asterisk denotes TCMs, which connect SC inner wall to the hinged collagen flaps. If 
the TM moves, the hinged collagen flaps must also move because of their attachment 
to the TCMs.57 (Reprinted with permission. ©2016. Kugler Publications. All rights 
reserved.)  
 
The aqueous veins  
Karl Ascher first described aqueous veins in the January issue of the American 
Academy of Ophthalmology, 1942.4 Ascher’s5 work is considered ground breaking 
because it demonstrated that aqueous is not stagnant but instead flows. Although 
many ophthalmologists today would regard this concept as self-evident, this was not 
appreciated prior to Ascher. His work prompted research interest into aqueous 
physiology, outflow routes, and the mechanisms regulating IOP.  
 
In 1961, Ascher5 published The Aqueous Veins, an extensive analysis of the anatomy 
and physiology of these structures. Aqueous veins are epithelial-lined vessels in the 
conjunctival and subconjunctival tissue that return aqueous humour to the systemic 
circulation.5 They arise either directly from SC by a hook-shaped origin or indirectly 
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via the deep scleral plexus.6 They are visible on the surface of the eye and are 
distinguished from blood vessels by their pale colour and transparency.5 Usually 2-3 
aqueous veins are visible but up to 6 may be seen in some eyes.18 Their distribution 
around the limbus is asymmetric, with the majority of aqueous veins located in the 
infero-nasal quadrant, followed by the infero-temporal quadrant.18 Few are seen 
superiorly.18 Ascher5 noted pulsatile flow within the veins, but was unable to explain 
the significance of this and the observation unfortunately went largely ignored for 
over 50 years. Today, trabecular MIGS has revitalised interest in aqueous veins as 
these vessels permit direct visualisation of how canal-based procedures enhance 
aqueous outflow. It should also be noted that surgery on the conjunctiva, episclera and 
sclera can damage these vessels, as well as other downstream collectors, and thereby 
increase the resistance of the distal system.  
 
Micro-invasive glaucoma surgery (MIGS): theory into practice   
MIGS and ‘MIGS-like’ procedures aim to lower IOP by targeting three different 
outflow pathways: trabecular drainage, suprachoroidal drainage, and subconjunctival 
drainage.15 The scientific rationale of MIGS procedures is founded upon the outflow 
resistance studies that have been discussed in this paper. For instance, the rationale for 
many of the trabecular devices is based on the supposition that the majority of 
trabecular outflow resistance is located in the TM and inner wall of SC. Only if this 
traditional model is accepted can many of the devices be considered to have a firm 
evidence base for their design. The scientific rationale for and theoretical limitations 
of trabecular and suprachoroidal MIGS procedures are summarized in Table 1.  
 
Trabecular MIGS devices 
It is self-evident that trabecular MIGS procedures require a healthy downstream 
collector system and normal EVP to work well. However, it is suspected that various 
stressors may cause the downstream collectors to become dysfunctional, or even 
undergo atrophy. Such stressors include advanced age, surgery (i.e. cautery of the 
sclera), and long-standing glaucoma causing SC closure, collector system stasis and 
collapse. It is biologically plausible that there is an optimal window of time for 
trabecular MIGS in the natural history of open-angle glaucoma. Even individuals with 
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advanced glaucoma may once have been good candidates for trabecular MIGS while 
their downstream collector system was still healthy. 
 
Before proceeding with trabecular MIGS it is important to assess the health of the 
downstream collector system. Certain clinical signs can help in deciding whether the 
collector system is functional (or at least amenable to rejuvenation), or whether the 
system should be abandoned in favour of the suprachoroidal or subconjunctival route. 
On history, a functioning trabecular pathway is suggested by a favourable response to 
selective laser trabeculoplasty (SLT) or pilocarpine. On examination, one can observe 
for pulsatile flow within aqueous veins or blood reflux into SC on gonioscopy. Blood 
reflux can be triggered by applying pressure to the episcleral vessels with a flanged 
gonioscope, by “pumping” a gonioscope on the cornea to generate a suction effect on 
the eye, or by lowering IOP below EVP. Robert Stegmann’s37 team correlated blood 
reflux into SC with fluorescein egress into episcleral veins in individuals with POAG 
undergoing canaloplasty. At the start of the operation, the IOP was lowered with a 
paracentesis and gonioscopy was performed to grade blood reflux into SC. 
Fluorescein chanellography and canaloplasty was then performed using a 
microcatheter. Individuals with good circumferential blood reflux into SC had 
excellent fluorescein egress into episcleral veins, whereas those with patchy or no 
blood reflux into SC had much poorer fluorescein egress.37 The results suggest that 
eyes that do not have blood reflux into SC do not have a patent distal collector 
system, at least in that region of the angle. When SC blood reflux is observed, the 
speed at which SC fills with blood, and then empties of blood during dynamic 
manoeuvres, is thought to reflect the health of the downstream collectors.78,79 
 
Trabecular meshwork pigment can be used to locate CCEs and areas of functioning 
angle. Drainage through the TM occurs preferentially near high-flow collector 
channels, indicating that aqueous flow across the TM is sensitive to downstream 
pressure.45 This has been demonstrated experimentally using enucleated healthy 
human eyes perfused with fluorescent beads. Beads are found to accumulate in 
pigmented TM near CCEs,45 and by the same process, pigment floating in the aqueous 
tends to deposit in TM adjacent to functioning CCEs.  
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If a trabecular microbypass procedure is performed to a focal area of angle selected at 
random then Rosenquist’s77 study of 1989 would predict only a modest IOP 
reduction. In enucleated human eyes perfused at an IOP of 25mmHg, a one-clock 
hour trabeculotomy produced 41% of the effect of a twelve-hour trabeculotomy (Fig. 
3). Given that the effective filtration area comprises only a fraction of the total angle, 
and that there is minimal circumferential flow within SC, placing a microbypass stent 
in meshwork remote from a functioning CCE may have minimal effect. Greater IOP 
reductions can be expected if microbypass is targeted to sites of high flow collector 
channels. Fortunately, these are most numerous in the inferonasal and superonasal 
quadrants, which is surgically convenient. In keeping with this, in 1971, Ellingsen and 
Grant22 reported that trabeculotomies made in the nasal hemisphere increased outflow 
more than trabeculotomies made in the temporal hemisphere. Functioning collectors 
can be further targeted by looking for segments of angle with increased TM pigment 
or increased (and brisk) blood reflux into SC.   
 
As discussed earlier, Rosenquist77 also found that circumferential trabeculotomy 
reduced outflow resistance by up to 49% at low IOPs (7mmHg) but up to 75% at 
higher IOPs (25mmHg). This suggests that the resistance of the downstream 
collectors is relatively stable and unchanged by IOP, whereas the resistance of the TM 
varies with IOP. At higher pressures, TM resistance increases (due to SC collapse) 
and accounts for a higher proportion of the total resistance. The clinical significance 
of this is that individuals with high IOP may get significant benefit from procedures 
that address both TM resistance and SC collapse (such as Hydrus or goniotomy). In 
contrast, individuals with low IOPs would be expected to have less response to this 
intervention and may need a treatment that addresses downstream resistance (such as 
viscocanaloplasty) to achieve IOP reduction.  
 
Given the mounting evidence suggesting that SC closure and TM herniations into 
CCEs play an important role in glaucoma, the ideal trabecular MIGS procedure would 
address trabecular permeability, SC occlusion, TM herniations into CCEs, and 
downstream resistance. In theory, microbypass devices may reduce the pressure 
gradient across the TM and therefore reduce TM excursion, however they don’t 
directly prevent SC closure. In contrast, an intracanalicular scaffold would be 
expected to prevent SC closure in the quadrant of the device.  
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Suprachoroidal MIGS devices 
Suprachoroidal MIGS devices bypass the ciliary body resistance to form a direct 
communication between the anterior chamber and the suprachoroidal space. The huge 
absorptive capacity of the choroidal vasculature makes hypotony possible with this 
route. However, hypotony can potentially be limited by the device itself. Long-term, 
the main factor limiting IOP control is encapsulation of the device by scar tissue.1 The 
healing response is less pronounced with ab interno devices that spare the need for 
conjunctival and scleral dissection.29 In the future it may be possible to modulate this 
healing response with the use of antifibrotic agents, drug-eluting stents, and expansion 
of the suprachoroidal reservoir with ophthalmic viscosurgical devices.91 
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Anatomic target  Scientific rationale Theoretical limitations  















Increases trabecular outflow by one or more of: 
1. Increasing TM permeability  
2. Preventing SC collapse  
3. Reversing TM herniations into CCEs 
4. Viscodilating downstream collectors 
 
Outcome is dependent upon the extent of angle treated 
and the health of the downstream collector system. 
Increased TM pigment and brisk blood reflux into SC 
suggest a functioning downstream system. IOPs in the 
very low teens can be achieved with healthy collectors,44 
whereas higher IOPs are expected with collector 
dysfunction.  
Cannot lower IOP below EVP (but therefore 
low risk of hypotony).  
 
May damage endothelium of SC and CCEs, 
leading to scarring/stenosis. 
 
Hyphaemas (including late hyphaemas) if IOP 
falls below EVP, such as may occur if filtration 
surgery is performed later.30 
 
It is unknown how these procedures affect 
hinged collaged flaps at CCEs. Hinged collagen 
flaps may also have independent contractile 
mechanisms that would likely be unaffected.17 
Procedures localized to 
segments of angle (e.g. iStent 
trabecular microbypass, Hydrus 
Provides a portion of the increase in outflow achieved 
with a circumferential trabeculotomy (see Fig 3).  
 
Aqueous outflow is segmental. Devices that 
treat only small segments of angle are likely to 
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intracanalicular scaffold, ELT, 
Kahook Dual Blade, 
Trabectome) 
Magnitude of IOP reduction maximised by targeting 
functioning CCEs and aqueous veins. These are most 
numerous in the infero-nasal quadrant.5,21,46,76 Supported 
by experimental evidence that trabeculotomies made in 
nasal hemisphere increase outflow more than 
trabeculotomies made in temporal hemisphere.22  
be less effective, unless placed near large CCEs 
or aqueous veins arising directly from SC.  
 
Do not address dynamic influences on outflow 
resistance, such as appositional closure of SC 
and TM herniations into CCEs (partially 
addressed by Hydrus, trabectome, and Kahook 





Focally bypasses TM permeability resistance.  
Implanting multiple devices increases the success,19 given 
increased likelihood of positioning at least one of the 
devices near a functioning CCE.45 
May possibly preserve the trabecular pumping 
mechanism. 
Hydrus intracanalicular scaffold 
Prevents SC collapse and stretches the TM over the 
windows, which may increase TM permeability.  
ELT 
Makes full thickness ostia in TM and inner wall of SC to 
bypasss TM permeability resistance. 
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Kahook Dual Blade or Trabectome 
Physically removes the TM and inner wall of SC to 
overcome permeability resistance and prevent SC 
collapse and TM herniations into CCEs. 
Procedures addressing entire 
angle (e.g. GATT) 
The perfusion studies of Grant and colleagues would 
predict that 360 degree trabeculotomy should remove 
approximately 50% of outflow resistance for eyes with an 
IOP in the low teens, and approximately 75% of outflow 
resistance for eyes with an IOP of approximately 
25mmHg – 33mmHg.77 
 
By disinserting TM, GATT should remove TM 
herniations into CCEs and prevent SC collapse.  
Complete disruption of the trabecular pumping 
mechanism. 
  
Ab interno canaloplasty  Viscodilation attempts to restore patency of SC and the 
downstream collector channels, and unplug herniations of 
TM into CCEs. 
 
Causes “microperforations” in TM and SC inner wall, 
which may increase TM permeability. 
In advanced glaucoma, downstream collector 
system may be atrophic and not amenable to 
rejuvenation with viscodilation.37 
 
The duration of action of ab interno 
viscodilation is unknown and would be 
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Table 1. Scientific rationale for and theoretical limitations of trabecular and suprachoroidal MIGS, based on aqueous drainage physiology.  
expected to be transient, especially without 
placement of a tensioning suture in the canal. 
However, there is some evidence that the 
therapeutic response is sustained at least in the 
medium term.33,66 
  
Does not prevent SC collapse. 
Suprachoroidal devices  
Ab interno suprachoroidal 
devices (e.g. CyPass, iStent 
Supra) 
Provides direct communication between AC and the 
suprachoroidal space. Bypasses the ciliary muscle, which 
is thought to be the main site of resistance in non-
trabecular flow.29,50  
 
Increases the IOP sensitivity of the non-trabecular 
pathway. 
 
Does not affect structural integrity and dynamic motion 
of TM, therefore not expected to disrupt trabecular 
pump.52 
Does not address trabecular outflow resistance. 
 
Unique risk profile, including risk of hypotony. 
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Key: AC, anterior chamber; CCEs, collector channel entrances; EVP, episcleral venous pressure; ELT, excimer laser trabeculostomy; GATT, 




It is appropriate to move towards an integrated model whereby the TM, SC, collector 
channels, and distal outflow pathways function as a sophisticated organ system that 
works in unison to control trabecular outflow.13 Therefore, abnormalities in both the 
proximal and distal portions of the system are important in understanding loss of IOP 
homeostasis in glaucoma.13  
 
The perfect glaucoma procedure would rejuvenate the outflow systems of the eye to 
their premorbid state and direct aqueous down physiologic routes. This would require 
restoring normal flexibility and permeability of the TM and SC, rejuvenating the 
downstream collector system, and reducing ciliary muscle resistance. No current 
single procedure achieves all of these goals, but improvements in technology may 
allow us to bridge this gap. It is conceivable that a targeted procedure, likely 
incorporating sustained drug delivery, could consistently obtain a very low IOP with 
minimal complications. In addition, the development of imaging modalities to assess 
the health of the distal collector system pre-operatively would help with 
prognostication and patient selection for trabecular procedures.  
 
For individuals with early glaucoma and a functional downstream collector system, 
goniotomy or multiple targeted trabecular bypass devices (that ideally prevent SC 
collapse) may be an appropriate strategy unless a very low IOP target is required. 
Goniotomy needs to be circumferential or near-circumferential to maximise trabecular 
outflow.77 In more advanced glaucoma with dysfunctional collectors, or in individuals 
requiring lower IOPs, trabecular bypass could be combined with viscocanaloplasty to 
reduce the resistance of the downstream collectors. However, this approach may be 
ineffective in very late cases where the distal system is atrophic. Alternatively, one 
could choose a suprachoroidal device, after considering its unique risk profile. A key 
advantage of canal-based procedures is that there is theoretically no risk of hypotony.  
 
A clear understanding of outflow function and dysfunction has become more 
important in this era of MIGS procedures with very specific mechanisms of action. 
We hope that by meticulously reviewing outflow anatomy and physiology, and 
bringing to light historical findings that may have been forgotten or overlooked, we 
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may help to optimize the surgical treatment of glaucoma and ultimately reduce 
glaucoma blindness worldwide.  
 
Methods of literature search 
In preparing this review, we conducted PubMed, EMBASE, and Google Scholar 
searches using the following key words in various combinations: aqueous, outflow 
resistance, micro-invasive glaucoma surgery, glaucoma, aqueous veins, Schlemm’s 
canal, and collector channel entrances. In addition, reference lists from the selected 
articles were used to identify additional articles not included in the electronic 
databases. This included hard copy and electronic textbooks, which were accessed 
from various libraries. From the searches, all articles pertaining to the relevant topic 
were included in this review. No constraints were placed on publication date or 
publication language.   
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